This inventor holds 1 USPTO granted patent. Top assignee: Miles Laboratories, Inc.. Active years: 1984.
Company Filing History:
Years Active: 1984
Title: The Innovations of David C. Atkinson
Introduction
David C. Atkinson is a notable inventor based in Elkhart, IN (US). He has made significant contributions to the field of immunoassay methods, particularly in the determination of iodothyronines in biological fluids. His innovative approach has led to the development of a unique patent that enhances the accuracy and efficiency of immunoassays.
Latest Patents
David C. Atkinson holds a patent for "Substituted phenylacetic acids and salts as TBP blocking agents in an improved immunoassay method, reagent means, and test kit for determining an iodothyronine, e.g., thyroxine (T-4), in a biological fluid." This invention utilizes fenclofenac and related phenylacetic acids as novel blocking agents for the binding of iodothyronines to thyroxine binding protein (TBP). The method is particularly advantageous for homogeneous competitive binding iodothyronine immunoassays, generating a spectrophotometric response at wavelengths greater than 300 nm, where the blocking agents exhibit no substantial absorbance.
Career Highlights
Atkinson's career is marked by his work at Miles Laboratories, Inc., where he has applied his expertise in immunoassay development. His innovative contributions have not only advanced the field but have also provided practical solutions for medical diagnostics.
Collaborations
Throughout his career, David has collaborated with notable colleagues, including Robert J. Carrico and David L. Morris. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
David C. Atkinson's work exemplifies the spirit of innovation in the field of immunoassays. His patented methods and collaborative efforts have significantly impacted medical diagnostics, showcasing the importance of creativity and teamwork in scientific advancements.